Literature DB >> 6601051

Small albumin-immunoglobulin complexes in patients with liver disease.

Q Y Zhen, S Walther, C P Sodomann.   

Abstract

Circulating immune complexes (CIC) with a molecular weight (M.W.) of 1.4-1.6 x 10(6) were observed in patients with liver disease. CIC containing abnormal albumin were found in patients with chronic active hepatitis. The abnormal albumin from CIC displayed an apparent M.W. of 105-110,000 on Sephadex G-100 and Sepharose 6B column chromatograph before reduction, and only 50,000 on reduced sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE). It is postulated that abnormal albumin contained within CIC may be a dimeric-S-S-linked small albumin (sAlb-S-)2. Immunoglobulins in the CIC containing (sAlb-S-)2 were identified as IgM and IgG. Based on the constituents of CIC and their M.W., the assumed molecular formula of CIC is (IgM)1 (sAlb-S-)2 (IgG)3. Cause and effect of these CIC in liver disease, especially a possible role of altered host components in the initiation of autoimmune reactions, are discussed.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6601051      PMCID: PMC1454064     

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  22 in total

1.  Detection and characterization of circulating immune complexes by ultracentrifugation. Technical aspects.

Authors:  J Benveniste; C Bruneau
Journal:  J Immunol Methods       Date:  1979       Impact factor: 2.303

2.  Detection of hepatitis B antigen in circulating immune complexes in acute and chronic hepatitis.

Authors:  G Carella; M Digeon; G Feldmann; P Jungers; J Drouet; J F Bach
Journal:  Scand J Immunol       Date:  1977       Impact factor: 3.487

3.  Rabbit C1q: purification, functional and structural studies.

Authors:  J E Volanakis; R M Stroud
Journal:  J Immunol Methods       Date:  1972-11       Impact factor: 2.303

4.  Virus-like antigen, antibody, and antigen-antibody complexes in hepatitis measured by complement fixation.

Authors:  N R Shulman; L F Barker
Journal:  Science       Date:  1969-07-18       Impact factor: 47.728

5.  The reliability of molecular weight determinations by dodecyl sulfate-polyacrylamide gel electrophoresis.

Authors:  K Weber; M Osborn
Journal:  J Biol Chem       Date:  1969-08-25       Impact factor: 5.157

6.  [Circulating immune complexes in liver diseases (author's transl)].

Authors:  C P Sodomann; K Prokein; H Schmidt; G A Martini
Journal:  Z Gastroenterol       Date:  1978-08       Impact factor: 2.000

7.  DEAE-cellulose chromatography: a method for dissociation of soluble immune complexes of hepatitis B antigen.

Authors:  K Madaliński; A Sztachelska-Budkowska; W J Brzosko
Journal:  J Infect Dis       Date:  1974-04       Impact factor: 5.226

8.  Detection of immune complexes in unheated sera by modified 125I-Clq binding test. Effect of heating on the binding of Clq by immune complexes and application of the test to systemic lupus erythematosus.

Authors:  R H Zubler; G Lange; P H Lambert; P A Miescher
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

9.  Methods for detection of anti-albumin autoantibodies in hepatic diseases.

Authors:  R Lenkei; V Ghetie
Journal:  J Immunol Methods       Date:  1977       Impact factor: 2.303

10.  Nephelometric detection of soluble immune complexes: methodology and clinical applications.

Authors:  G Virella; W A Hipp; J F John; B Kahaleh; M Ford; H H Fudenberg
Journal:  Int Arch Allergy Appl Immunol       Date:  1979
View more
  2 in total

1.  Protein composition of circulating immune complexes in patients with periodic disease complicated or not complicated by renal amyloidosis.

Authors:  G M Mkrtchyan; A S Boyajyan; K G Karageuzyan; A A Aivazyan; S A Pashinyan; E E Nazaretyan
Journal:  Dokl Biol Sci       Date:  2002 Jul-Aug

2.  What proteins are present in polyethylene glycol precipitates from rheumatic sera?

Authors:  M W Robinson; D G Scott; P A Bacon; K W Walton; J S Coppock; D L Scott
Journal:  Ann Rheum Dis       Date:  1989-06       Impact factor: 19.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.